Search | WHO COVID-19 Research Database

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Hermans, Cedric; Astermark, Jan; Carvalho, Manuela; Dolan, Gerry; d'Oiron, Roseline; Fontana, Pierre; Holme, Pål André; Kenet, Gili; Klamroth, Robert; Mancuso, Maria Elisa; Marquardt, Natascha; Nunez, Ramiro; Katsarou, Olga; Pabinger-Fasching, Ingrid; Quintavalle, Gabriele; Rodgers, Ryan; van der Valk, Paul; Windyga, Jerzy; Jimenez Yuste, Victor; Preloznik Zupan, Irena.

Haemophilia ; 29(3): 913-916, 2023 05.

Article in English | MEDLINE | ID: covidwho-2262720

Subject(s)

COVID-19 , Hemophilia A , Adult , Humans , Hemophilia A/complications , Hemophilia A/epidemiology , Prevalence , COVID-19/epidemiology , Europe/epidemiology , Hospitalization

Severe bleeding in a patient with factor XIII deficiency and COVID-19.

Quintavalle, Gabriele; Coppola, Antonio; Ruggieri, Alessandro; Rivolta, Gianna Franca; Fronti, Elisa; Giangregorio, Francesco; Michieletti, Emanuele; Tagliaferri, Annarita.

Haemophilia ; 27(1): e140-e142, 2021 Jan.

Article in English | MEDLINE | ID: covidwho-1066682

Subject(s)

COVID-19/complications , Factor XIII Deficiency/complications , Factor XIII Deficiency/virology , Hemorrhage/complications , Hemorrhage/virology , COVID-19/blood , Female , Hemorrhage/pathology , Humans , Middle Aged , SARS-CoV-2/isolation & purification

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.

Coppola, Antonio; Tagliaferri, Annarita; Rivolta, Gianna Franca; Quintavalle, Gabriele; Franchini, Massimo.

Semin Thromb Hemost ; 46(7): 819-822, 2020 10.

Article in English | MEDLINE | ID: covidwho-593025

Subject(s)

Betacoronavirus , Coronavirus Infections/epidemiology , Hemophilia A/therapy , Hemophilia B/therapy , Pandemics , Pneumonia, Viral/epidemiology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Antibodies, Bispecific/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , COVID-19 , Clinical Trials as Topic , Comorbidity , Continuity of Patient Care , Contraindications, Drug , Coronavirus Infections/blood , Coronavirus Infections/complications , Coronavirus Infections/prevention & control , Delivery of Health Care , Disease Management , Drug Substitution , Factor IX/supply & distribution , Factor IX/therapeutic use , Factor VIII/supply & distribution , Factor VIII/therapeutic use , Fibrinolytic Agents/adverse effects , Fibrinolytic Agents/therapeutic use , Genetic Therapy , Health Resources/supply & distribution , Hemophilia A/complications , Hemophilia A/epidemiology , Hemophilia B/complications , Hemophilia B/epidemiology , Hemorrhage/etiology , Hemorrhage/prevention & control , Humans , Pandemics/prevention & control , Pneumonia, Viral/blood , Pneumonia, Viral/complications , Pneumonia, Viral/prevention & control , Professional-Patient Relations , SARS-CoV-2 , Social Media , Telemedicine , Thrombophilia/etiology

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL